FMP
NYSE
13.89 USD
-0.3 (-2.16%)
Mr. Christophe Weber
Healthcare
Drug Manufacturers - Specialty & Generic
https://www.takeda.com
NYSE
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab, Alofisel, Dexilant, Natpara, Adynovate/Adynovi, Takhzyro, Livtencity, Elaprase, Replagal, Advate, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, Velcade, Leuplin/Enantone, Adcetris, Vyvansese, Trintellix, and Alunbrig brand...
0001395064
US8740602052
874060205
1-1, Nihonbashi-Honcho 2-chome
81 3 3278 2111
JP
49,095
Jan 5, 2010
0001395064
NYSE
Drug Manufacturers -...
Healthcare
874060205
US8740602052
JP
13.89
0.54
1.84M
43.58B
-
13.19-17.15
321.09
-
-
-
-
37.54
-
https://www.takeda.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.